FDA approves new pancreatic cancer drug that could extend patients' lives ...Middle East

CBS News - Cultural
FDA approves new pancreatic cancer drug that could extend patients lives
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.

Hence then, the article about fda approves new pancreatic cancer drug that could extend patients lives was published today ( ) and is available on CBS News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves new pancreatic cancer drug that could extend patients' lives )

Apple Storegoogle play

Last updated :

Also on site :



Latest News